Af­ter leav­ing Mer­ck­'s C-suite, Mike Nal­ly turns up at the helm of a Flag­ship ma­chine learn­ing com­pa­ny

It’s been two weeks on the dot since Mike Nal­ly said he would leave the chief mar­ket­ing post at Mer­ck, where he was re­port­ed­ly in the run­ning to re­place CEO Ken Fra­zier, for an­oth­er lead­er­ship op­por­tu­ni­ty.

Now we know where he’s head­ed.

The Har­vard Busi­ness School grad­u­ate is re­turn­ing to Cam­bridge, MA, where he’ll be­come Flag­ship Pi­o­neer­ing’s lat­est CEO-part­ner and take the helm at Gen­er­ate Bio­med­i­cines — a ma­chine-learn­ing fo­cused up­start that emerged from a three-year stealth pe­ri­od in Sep­tem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER